CASI Pharmaceuticals Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
CASI Pharmaceuticals (CASI) Reports Q1 Loss of $0.06/Share
May 15, 2015 7:03 AM EDTCASI Pharmaceuticals (NASDAQ: CASI) reported Q1 EPS of ($0.06), versus ($0.05) reported last year. Revenue for the quarter came in at $23.7 thousand, versus $0 reported last year.
For earnings history and earnings-related data on CASI Pharmaceuticals (CASI) click here.
... More


